Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,289 | 90,121 | 106,092 | 201,661 | 122,661 |
| Marketable Securities | N/A | 93,822 | 127,703 | 46,459 | 233,663 |
| Receivables | N/A | 206 | 157 | 50 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 450 |
| TOTAL | $118,546 | $187,635 | $243,052 | $253,348 | $361,317 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 930 | 1,549 | 812 |
| Other Non-Current Assets | 0 | 3,161 | 33,097 | 31,697 | 8,692 |
| TOTAL | $N/A | $3,161 | $34,027 | $33,246 | $9,504 |
| Total Assets | $118,546 | $190,796 | $277,079 | $286,594 | $370,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 247 | 6,761 | 3,004 | 8,361 | 963 |
| Accrued Expenses | 4,992 | 10,086 | 13,985 | 20,152 | 7,530 |
| Other current liabilities | N/A | 739 | 56 | 1,742 | 572 |
| TOTAL | $5,239 | $28,367 | $24,338 | $37,853 | $12,294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 16,648 | 28,222 | 23,475 | 5,463 |
| TOTAL | $N/A | $16,648 | $28,222 | $23,475 | $5,463 |
| Total Liabilities | $5,239 | $45,015 | $52,560 | $61,328 | $17,757 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,043 | 4,997 | 4,066 | 2,843 | 2,832 |
| Common Shares | N/A | N/A | 9 | 7 | 7 |
| Retained earnings | -714,962 | -656,193 | -465,775 | -297,065 | -125,103 |
| Other shareholders' equity | -135 | -62 | -468 | -155 | -112 |
| TOTAL | $113,307 | $145,781 | $224,519 | $225,266 | $353,064 |
| Total Liabilities And Equity | $118,546 | $190,796 | $277,079 | $286,594 | $370,821 |